Journal
AUTOIMMUNITY REVIEWS
Volume 8, Issue 3, Pages 244-249Publisher
ELSEVIER
DOI: 10.1016/j.autrev.2008.07.037
Keywords
MIF; Autoimmunity; Inflammation
Categories
Funding
- Serbian Ministry of Science [143029]
Ask authors/readers for more resources
Macrophage migration inhibitory factor (MIF) is a multipotent cytokine implicated in the pathogenesis of numerous inflammatory and autoimmune disorders. Since anti-cytokine therapy is considered to be a promising therapeutic strategy, selective targeting of MIF with either anti-MIF antibody or specific chemical MIF inhibitors might offer new therapeutic avenues for these disorders. Considering the unique relationship between MIF and glucocorticoids, therapeutic antagonism of MIF could also represent an effective approach for steroid-sparing therapies in patients with refractory autoimmune diseases. (c) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available